Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AKBA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Akebia Therapeutics stock price on Thursday moving between $1.77 and $2.47
(Updated on Mar 28, 2024)

Buy or Hold candidate since Mar 15, 2024 Gain 7.65% PDF

The Akebia Therapeutics stock price fell by -18.30% on the last day (Thursday, 28th Mar 2024) from $2.24 to $1.83. During the last trading day the stock fluctuated 39.55% from a day low at $1.77 to a day high of $2.47. The price has risen in 7 of the last 10 days and is up by 33.58% over the past 2 weeks. Volume has increased on the last day by 52 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 60 million shares were bought and sold for approximately $110.52 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 22.13% during the next 3 months and, with a 90% probability hold a price between $1.75 and $2.74 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AKBA Signals & Forecast

The Akebia Therapeutics stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $2.06. On a fall, the stock will find some support from the long-term average at approximately $1.64. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, March 27, 2024, and so far it has fallen -18.30%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Akebia Therapeutics stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.70 and $1.64. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Akebia Therapeutics finds support just below today's level at $1.70. If this is broken, then the next support from accumulated volume will be at $1.64 and $1.47.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.700 between high and low, or 39.55%. For the last week, the stock has had daily average volatility of 17.87%.

Our recommended stop-loss: $1.74 (-4.82%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (AKBA) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Akebia Therapeutics to open at $2.02, and during the day (based on 14 day Average True Range), to move between $1.61 and $2.05, which gives a possible trading interval of +/-$0.218 (+/-11.89%) up or down from last closing price. If Akebia Therapeutics takes out the full calculated possible swing range there will be an estimated 23.78% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.89 (3.28%) than the support at $1.70 (7.10%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Akebia Therapeutics stock A Buy?

Akebia Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold/Accumulate candidate.

Current score: -0.243 Hold/Accumulate Downgraded

Predicted Opening Price for Akebia Therapeutics of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$2.02 ( 10.56%) $1.83

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AKBA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.72 48.82 %
R2 2.46 34.20 %
R1 2.29 25.18 %
Current price: 1.83
Support S1 1.76 -4.05 %
S2 1.59 -13.07 %
S3 1.32 -27.69 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.24 22.40 %
R2 2.00 9.29 %
R1 1.89 3.28 %
Current price 1.83
Support S1 1.70 -7.10%
S2 1.64 -10.38%
S3 1.47 -19.67%

FAQ

What is the symbol for Akebia Therapeutics Stock and on which exchange is it traded?
The symbol for Akebia Therapeutics is AKBA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Akebia Therapeutics Stock?
Akebia Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold/Accumulate candidate.

How to buy Akebia Therapeutics Stock?
Akebia Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Akebia Therapeutics Stock.

What's the current price of Akebia Therapeutics Stock?
As of the end of day on the 2024-03-28, the price of an Akebia Therapeutics (AKBA) share was $1.83.

What is the 52-week high and low for Akebia Therapeutics Stock?
The 52-week high for Akebia Therapeutics Stock is $2.47 and the 52-week low is $0.490.

What is the market capitalization of Akebia Therapeutics Stock?
As of the 2024-03-28, the market capitalization of Akebia Therapeutics is 418.744M.

When is the next earnings date for Akebia Therapeutics?
The upcoming earnings date for Akebia Therapeutics is May 13, 2024.
Click to get the best stock tips daily for free!

About Akebia Therapeutics

Akebia Therapeutics Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citra... AKBA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT